?
Combination therapies**: Could TRPA1 antagonists be combined with disease-modifying approaches (anti-Aβ, anti-αSyn) for synergistic benefit in AD/PD?
active
open question
Created: 2026-04-25T20:29:34
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-6ab813b5-6633-4fdb-98c1-de
Open Question
open
Wiki: genes-trpa1
Combination therapies**: Could TRPA1 antagonists be combined with disease-modifying approaches (anti-Aβ, anti-αSyn) for synergistic benefit in AD/PD?
Importance Elo
1500
Field Rank
Rank #1439 in genes
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page genes-trpa1
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:34.952702'} |
| field_tag | genes |
| source_id | genes-trpa1 |
| sub_field | trpa1 |
| source_kind | wiki |
| question_hash | cfd618aeb7cd41d8cae9f2cbad91a42ffe57db5c07e56295473e1074c48a04d6 |
| question_text | Combination therapies**: Could TRPA1 antagonists be combined with disease-modifying approaches (anti-Aβ, anti-αSyn) for synergistic benefit in AD/PD? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page genes-trpa1 |
| evidence_xref_at | 2026-04-27T13:31:57.844848+00:00 |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.